Sr. Director, Global Clinical Ancillary Services

Thermo Fisher Scientific•Center Valley, PA

22h•Onsite

About The Position

The General Manager & Business Segment Leader – Global Clinical Ancillary Services (GCAS) is responsible for a global ancillaries business that supports both the direct-to-sponsor / direct-to-patient clinical trial model within the Clinical Trials Division and the Contract Research Organization (CRO) business, while remaining CRO-agnostic and able to partner effectively with any CRO. You will lead a full-scale global organization spanning business development, procurement, client services, operations and an ancillaries distribution network, and will shape how Thermo Fisher delivers end-to-end clinical ancillary solutions as part of broader clinical supply offerings. In this role, you will develop and execute strategies for profitable, sustainable growth in a fast-growing, fragmented ancillaries market. You will leverage the full portfolio of clinical supply solutions and ancillaries services, Thermo Fisher’s buying power, and our global footprint to deliver innovative, compliant, patient-centric, and cost-effective solutions that help customers run better trials and improve patient access worldwide. What will you do? Provide leadership for Global Clinical Ancillary Services (GCAS), a global business segment that supports Clinical Trials Division customers and CRG/PPD, and other CRO partners, while maintaining a CRO agnostic model. Develop and execute the Annual Operating Plan (AOP) and long-range strategic plan (e.g., STRAP) for GCAS in partnership with Finance, consistently delivering or exceeding commitments for revenue, organic growth, EBITA and margin expansion. Define and continually refine the value proposition and service portfolio for clinical ancillaries, including general ancillaries, monitoring devices (including eCOA), wearable sensors, home use diagnostic kits, and associated distribution and support services. Lead the evolution of GCAS as an active clinical trial ancillary partner by ensuring regional regulatory compliance, product traceability, scalable and flexible solutions, and delivery schedules that align with study protocols and key milestones (e.g., Site initiative visit (SIV)). Partner closely with Commercial and Operations leaders across CTD and CRG/PPD to build strategic customer relationships, expand ancillaries adoption in new and existing accounts, and grow a sustainable global pipeline of opportunities. Collaborate with key strategic programs such as the ‘Accelerator’ initiative driving collaboration across PSG and CRG to ensure GCAS ancillaries are effectively embedded into combined offerings, while preserving GCAS’ ability to support other CROs on an equal basis. Expand, manage and optimize a global depot and distribution network to enhance scalability, service levels, and quality, using CTD’s non-GMP ancillaries hubs and GMP network in the Americas, Europe, and APAC. Ensure a best-in-class customer and patient experience, driving improvements in key indicators such as Customer Allegiance Score (CAS), Net Promoter Score (NPS), on-time-in-full (OTIF) delivery, complaint rates, proposal turnaround times, and issue resolution. Champion intuitive, easy-to-use, patient-centric ancillary solutions that support adherence, data quality and therapeutic outcomes while reducing burden for clinical research sites and patients. Provide leadership for end-to-end operations across GCAS, including sourcing, supplier management, inventory and demand planning, kitting, labeling, distribution, returns, refurbishment and disposal of ancillaries and equipment. Build and develop a diverse, high performing global team, including leadership for business development, procurement, client services, depot, and operations functions. Ensure talent readiness, growth, succession, and a strong culture across all GCAS locations. Drive continuous improvement and operational excellence using Practical Process Improvement (PPI) and KPI-driven execution to simplify ways of working, increase productivity, and improve internal and external efficiency. Ensure robust quality, regulatory and compliance performance for GCAS, including adherence to applicable GxP, device regulations, trade and customs, and data privacy requirements across all regions. Maintain strong quality management systems for audits, inspections, deviations, CAPAs, complaints, and risk management. Oversee the technology roadmap for GCAS, including inventory and order visibility, device tracking and connectivity, data integration, and alignment with CTD and enterprise platforms to support a scalable, transparent and data driven operating model. Develop and maintain market and competitive intelligence in the clinical ancillaries space (including general ancillaries, rental equipment, and specialist CT supply providers) to inform strategy, portfolio evolution, innovation, and investment decisions. Model Thermo Fisher Scientific’s Leadership Competencies and values, promoting a culture of collaboration, accountability, inclusion, and innovation across GCAS and the wider Clinical Trials Division.

Requirements

Proven record of delivering strong business results and P&L performance in a complex, global environment, including ownership of revenue growth, margin expansion and capital investments.
Significant experience within the pharmaceutical, life sciences or clinical research industry, typically 10–15 years, with deep familiarity in at least one of: clinical supply chains, clinical ancillaries, clinical trial logistics, CRO operations or related domains.
5+ years of management experience leading large scale, multifunctional global teams, preferably including commercial, operations and support functions.
Deep understanding of clinical trial supply chains and ancillary services, including sourcing, procurement, depot and distribution models, and the specific needs of sponsors, CROs, sites and patients.
Knowledge of and experience with CRO business models, direct-to-client / direct-to-patient clinical trial models, and how ancillaries fit into the broader end-to-end clinical supply solutions.
Demonstrated ability to develop and execute business strategy across multiple channels (direct sponsor, CRO, hybrid), including STRAP/AOP planning, portfolio positioning, and pricing.
Strong analytical, financial, and operational acumen, with a track record of scaling organizations, improving productivity, and optimizing global networks (depots, suppliers, distribution partners).
Experience building and evolving a global service organization, including talent strategy, leadership development and culture building across multiple sites and functions.
Deep familiarity with operating in a GxP compliant, highly regulated global business, including device regulations, quality systems, audits/inspections, and risk management practices.
Effective communicator and relationship builder with strong influencing skills across matrixed environments, able to collaborate with CTD, CRG, other Thermo Fisher groups, external CROs, suppliers and customers.
Demonstrated ability to drive customer and patient-centric improvements, using CAS/NPS and other metrics to prioritize and deliver enhancements in service experience.
Strong orientation toward continuous improvement, using tools such as PPI and KPI dashboards to create disciplined execution, transparency, and accountability.
Bachelor’s degree in life sciences, engineering, supply chain, business, or related field required
Willingness and ability to travel approximately 25% of the time, including internationally, to customer sites, depots, operations, and Thermo Fisher locations.

Nice To Haves

Advanced degree (e.g., MS, MBA, PharmD) preferred.

Responsibilities

Provide leadership for Global Clinical Ancillary Services (GCAS), a global business segment that supports Clinical Trials Division customers and CRG/PPD, and other CRO partners, while maintaining a CRO agnostic model.
Develop and execute the Annual Operating Plan (AOP) and long-range strategic plan (e.g., STRAP) for GCAS in partnership with Finance, consistently delivering or exceeding commitments for revenue, organic growth, EBITA and margin expansion.
Define and continually refine the value proposition and service portfolio for clinical ancillaries, including general ancillaries, monitoring devices (including eCOA), wearable sensors, home use diagnostic kits, and associated distribution and support services.
Lead the evolution of GCAS as an active clinical trial ancillary partner by ensuring regional regulatory compliance, product traceability, scalable and flexible solutions, and delivery schedules that align with study protocols and key milestones (e.g., Site initiative visit (SIV)).
Partner closely with Commercial and Operations leaders across CTD and CRG/PPD to build strategic customer relationships, expand ancillaries adoption in new and existing accounts, and grow a sustainable global pipeline of opportunities.
Collaborate with key strategic programs such as the ‘Accelerator’ initiative driving collaboration across PSG and CRG to ensure GCAS ancillaries are effectively embedded into combined offerings, while preserving GCAS’ ability to support other CROs on an equal basis.
Expand, manage and optimize a global depot and distribution network to enhance scalability, service levels, and quality, using CTD’s non-GMP ancillaries hubs and GMP network in the Americas, Europe, and APAC.
Ensure a best-in-class customer and patient experience, driving improvements in key indicators such as Customer Allegiance Score (CAS), Net Promoter Score (NPS), on-time-in-full (OTIF) delivery, complaint rates, proposal turnaround times, and issue resolution.
Champion intuitive, easy-to-use, patient-centric ancillary solutions that support adherence, data quality and therapeutic outcomes while reducing burden for clinical research sites and patients.
Provide leadership for end-to-end operations across GCAS, including sourcing, supplier management, inventory and demand planning, kitting, labeling, distribution, returns, refurbishment and disposal of ancillaries and equipment.
Build and develop a diverse, high performing global team, including leadership for business development, procurement, client services, depot, and operations functions. Ensure talent readiness, growth, succession, and a strong culture across all GCAS locations.
Drive continuous improvement and operational excellence using Practical Process Improvement (PPI) and KPI-driven execution to simplify ways of working, increase productivity, and improve internal and external efficiency.
Ensure robust quality, regulatory and compliance performance for GCAS, including adherence to applicable GxP, device regulations, trade and customs, and data privacy requirements across all regions. Maintain strong quality management systems for audits, inspections, deviations, CAPAs, complaints, and risk management.
Oversee the technology roadmap for GCAS, including inventory and order visibility, device tracking and connectivity, data integration, and alignment with CTD and enterprise platforms to support a scalable, transparent and data driven operating model.
Develop and maintain market and competitive intelligence in the clinical ancillaries space (including general ancillaries, rental equipment, and specialist CT supply providers) to inform strategy, portfolio evolution, innovation, and investment decisions.
Model Thermo Fisher Scientific’s Leadership Competencies and values, promoting a culture of collaboration, accountability, inclusion, and innovation across GCAS and the wider Clinical Trials Division.